
On 25 August, the State Drug Administration (SDA) issued a notification of drug approval for [Spironolactone Tablets], a new Class 3 filing of Zhejiang Shenzhou Pharmaceutical Co.
The Company has officially received the approval letter from the State Drug Administration on 6 September.
Other information
Copyright©2022 Zhejiang Shenzhou Pharmaceutical Co., Ltd. All Rights Reserved
Service